Target intelligence / Profile preview

Farnesyl diphosphate synthase pseudogene (FDPSP9)

Target
FDPSP9
Molecular classification
Other, Pseudogene
01

Overview

Farnesyl diphosphate synthase pseudogene (FDPSP9) is a genomic DNA sequence that resembles the functional farnesyl diphosphate synthase (FDPS) gene but is non-coding and does not produce a functional enzyme. Unlike the active FDPS gene—which is crucial for isoprenoid biosynthesis, cholesterol/sterol pathways, and is a pharmacological target for several drugs—FDPSP9 has no known protein product, biological activity, or therapeutic relevance. Multiple FDPS pseudogenes are annotated in the human genome, but they do not serve as receptors, enzymes, or drug targets[2][4][8]. Key point: This target is *not a valid therapeutic target*; any biomedical or pharmaceutical relevance is due to misidentification with the active FDPS gene/protein. The pseudogene should not be confused with the functional farnesyl diphosphate synthase enzyme (FPPS/FDPS), which has established roles in metabolism and as a drug target[2].

Other names
FDPSP9Farnesyl diphosphate synthase pseudogene 9farnesyl pyrophosphate synthetase pseudogene 9dimethylallyltranstransferase pseudogene 9geranyltranstransferase pseudogene 9
02

Mechanism of action

None (mechanisms of action apply solely to the active FDPS enzyme[5])

03

Biological functions

None (as a pseudogene, it does not encode a protein and thus has no direct biological functions)
04

Disease associations

None (no disease associations; any links to disease refer to the functional enzyme FDPS, not this pseudogene)
05

Safety considerations

None (no therapeutic intervention, thus no safety concerns)
06

Interacting drugs

None (no drugs directly interact with the pseudogene; drugs such as bisphosphonates interact with the functional FDPS enzyme[2][5])
07

Biomarkers

None (not used as a biomarker for patient selection or efficacy monitoring)

Beyond the preview

Go deeper on Farnesyl diphosphate synthase pseudogene (FDPSP9).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Farnesyl diphosphate synthase pseudogene (FDPSP9).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call